Autobio Diagnostics Co., Ltd.
603658
Rang în acțiuni
#4904
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Preț acțiune
$5.15
Ultima sincronizare: 2026-10-22
Capitalizare de piață
$2.94B
Schimbare (1 zi)
0.97%
Schimbare (1 an)
-5.80%
Țară
CN
Tranzacționează Autobio Diagnostics Co., Ltd. (603658)
Categorie
Healthcare
Raport P/B pentru Autobio Diagnostics Co., Ltd. (603658)
Raport P/B la data de October 2026 TTM: 2.27
Conform celor mai recente rapoarte financiare și prețului acțiunilor Autobio Diagnostics Co., Ltd., raportul P/B actual (TTM) este 2.27. La sfârșitul anului 2024, compania avea un P/B de 2.92.
Istoricul raportului P/B pentru Autobio Diagnostics Co., Ltd. din 2011 până în 2026
Raport P/B la sfârșitul fiecărui an
| An | Raport P/B | Schimbă |
|---|---|---|
| 2026 (TTM) | 2.27 | -0.17% |
| 2025 | 2.27 | -22.45% |
| 2024 | 2.92 | -23.98% |
| 2023 | 3.84 | -17.13% |
| 2022 | 4.64 | 4.57% |
| 2021 | 4.44 | -53.90% |
| 2020 | 9.62 | -39.22% |
| 2019 | 15.83 | 57.82% |
| 2018 | 10.03 | -22.97% |
| 2017 | 13.02 | -2.75% |
| 2016 | 13.39 | 21.99% |
| 2015 | 10.98 | -30.81% |
| 2014 | 15.87 | -31.58% |
| 2013 | 23.19 | -32.83% |
| 2012 | 34.52 | -42.77% |
| 2011 | 60.32 | 0.00% |
Raport P/B pentru companii similare sau competitoare
| Companie | Raport P/B | Diferență raport P/B | Țara |
|---|---|---|---|
| 4.5801 | 102.11% |
US
|
|
| 3.0725 | 35.59% |
US
|
|
| 31.4903 | 1,289.63% |
US
|
|
| 4.9326 | 117.67% |
CN
|
|
| 6.8081 | 200.43% |
US
|
